Katja Meixner

Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre

Maria Hoeltzenbein, Evelin Beck, Katja Meixner et al. · Clinical Research in Cardiology · 2015 · 70 citations

Thrombosis, Venous Thrombosis, Maternal Cardiovascular Outcome +14

No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester – Evaluation of the national Embryotox cohort

Katarina Dathe, Anne‐Katrin Fietz, Lucas William Pritchard et al. · Reproductive Toxicology · 2018 · 34 citations

Adverse Pregnancy Outcome, Abortion, National Embryotox Cohort +11

Negligible risk of prenatal ductus arteriosus closure or fetal renal impairment after third‐trimester paracetamol use: evaluation of the German Embryotox cohort

Katarina Dathe, J Frank, Stephanie Padberg et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2019 · 27 citations · Full text

Safety of diclofenac use during early pregnancy: A prospective observational cohort study

Stephanie Padberg, Tatjana Tissen‐Diabaté, Katarina Dathe et al. · Reproductive Toxicology · 2018 · 22 citations

Maternal Complication, Clinical Epidemiology, Pediatrics +11

Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study

Katarina Dathe, Stephanie Padberg, Stefanie Hultzsch et al. · European Journal of Clinical Pharmacology · 2017 · 21 citations

First Trimester, Cox-2 Inhibitors, Maternal Cardiovascular Outcome +12